Can Chronic Systemic Scleroderma Alter the Soft Tissue Seal Around a Dental Implant Collar?

Introduction

For adults living with systemic sclerosis — commonly known as scleroderma — managing everyday health involves navigating a wide range of physical changes, including those affecting the mouth. One concern that arises with increasing frequency is whether this chronic autoimmune condition can compromise the soft tissue seal that forms around a dental implant collar.

This is a highly specific and clinically significant question. If you are living with scleroderma and have dental implants — or are considering them — it is entirely understandable to search for clear, accurate information before discussing your options with a dental professional.

This article explores how scleroderma and dental implant soft tissue integrity may interact, what the science tells us about tissue changes around the implant collar, and why a thorough individual clinical assessment is essential. It is intended to inform, not to alarm, and aims to help you approach your next dental consultation with greater confidence and clarity.

---

Featured Snippet: Quick Answer

Can scleroderma affect the soft tissue seal around a dental implant collar?

Yes, chronic systemic scleroderma can potentially alter the soft tissue seal around a dental implant collar. The condition causes progressive fibrosis and reduced tissue elasticity, which may impair the peri-implant mucosal attachment. This can increase susceptibility to bacterial infiltration and peri-implant disease. Individual assessment by a dental professional is essential.

---

What Is Systemic Scleroderma and How Does It Affect the Body?

Systemic sclerosis (SSc), more commonly referred to as scleroderma, is a chronic autoimmune connective tissue disease characterised by widespread fibrosis, vascular abnormalities, and immune dysregulation. It affects multiple organ systems, including the skin, joints, gastrointestinal tract, lungs, and cardiovascular system.

There are two main forms:

• Limited cutaneous systemic sclerosis (lcSSc): Skin fibrosis is largely confined to the hands, face, and forearms.
• Diffuse cutaneous systemic sclerosis (dcSSc): Fibrosis is more extensive and may involve the trunk and internal organs.

In terms of oral health, scleroderma presents a distinctive and often underappreciated set of challenges. Patients frequently experience:

• Microstomia — a progressive reduction in mouth opening caused by perioral skin tightening
• Xerostomia — dry mouth resulting from salivary gland fibrosis or secondary Sjögren's syndrome
• Widening of the periodontal ligament space, visible on dental radiographs
• Trigeminal neuropathy in some cases
• Mucosal friability and reduced tissue resilience

Each of these manifestations has direct implications for how soft tissue behaves around implant components, making pre-treatment evaluation especially important for this patient group.

---

Understanding the Soft Tissue Seal Around a Dental Implant Collar

Before examining how scleroderma may disrupt this structure, it is helpful to understand what the soft tissue seal around an implant collar actually is and why it matters.

When a dental implant is placed and the crown or abutment is fitted, the gum tissue surrounding the implant collar — the area just above the bone level — forms what is known as the peri-implant mucosa. This tissue must adhere tightly to the implant surface to create a biological seal that acts as a barrier against:

• Oral bacteria and plaque
• Food debris
• Inflammatory mediators

This seal is composed of several layers. The junctional epithelium attaches directly to the implant surface, and below it, connective tissue fibres run parallel to — rather than into — the implant (unlike the natural perpendicular Sharpey's fibres found around natural teeth). This makes the peri-implant seal inherently less robust than the equivalent attachment around a natural tooth.

For this seal to function well, the surrounding tissue must have adequate:

• Vascularity — to maintain tissue nutrition and immune response
• Collagen architecture — to provide structural integrity
• Adequate keratinised mucosal width — to resist mechanical and bacterial insult

If any of these properties are compromised by systemic disease, the seal becomes more vulnerable.

---

How Scleroderma May Disrupt Peri-Implant Mucosal Integrity

The relationship between scleroderma and dental implant soft tissue integrity is complex. The condition does not merely affect skin appearance — its fibrotic and vascular effects have direct consequences for the peri-implant microenvironment.

Fibrosis and Altered Collagen Architecture

Scleroderma is fundamentally a fibrotic disease. Excess collagen deposition replaces normal tissue architecture with rigid, disorganised fibrous tissue. In the oral mucosa, this means the gingival tissue surrounding an implant may:

• Lose its natural elasticity and pliability
• Become less effective at conforming tightly to the implant collar
• Demonstrate reduced ability to respond to minor trauma or bacterial challenge

The resulting gap — however microscopic — between the mucosal tissue and implant surface can allow pathogenic bacteria to colonise the peri-implant sulcus more readily.

Vascular Compromise

Raynaud's phenomenon, present in the vast majority of scleroderma patients, reflects the widespread microvascular disease central to the condition. Impaired peripheral microcirculation reduces blood supply to peripheral tissues, including the oral mucosa. Poor tissue vascularity can:

• Delay mucosal healing following implant placement
• Reduce local immune defence capacity
• Increase vulnerability to opportunistic peri-implant infection

Xerostomia and Altered Oral Flora

Dry mouth, whether caused by salivary gland fibrosis or secondary Sjögren's syndrome, significantly changes the oral environment. Saliva plays a vital antimicrobial role, and its reduction leads to:

• Increased plaque accumulation around the implant collar
• Elevated counts of cariogenic and periodontal pathogens
• Difficulty maintaining mechanical oral hygiene

This combination creates conditions in which the peri-implant seal is under sustained microbiological pressure.

---

Clinical Implications: Peri-Implant Disease Risk in Scleroderma Patients

Peri-implant diseases exist on a spectrum. Peri-implant mucositis refers to reversible inflammation of the soft tissue surrounding an implant, while peri-implantitis involves progressive bone loss around the implant and carries a more serious prognosis.

For patients with scleroderma, the conditions described above — compromised tissue architecture, impaired vascularity, and xerostomia — collectively elevate the risk of:

• Early or accelerated peri-implant mucositis
• Difficulty resolving inflammation once it is established
• Greater susceptibility to peri-implantitis if disease progresses undetected

It is important to note that this does not mean dental implants are always contraindicated in scleroderma patients. However, it does mean that the risk profile requires careful individual evaluation, transparent discussion between patient and clinician, and a robust maintenance plan.

If you are exploring tooth replacement options and have a systemic condition, reviewing dental implant treatment options with a clinician experienced in medically complex cases is an important first step.

---

The Science Behind Peri-Implant Mucosal Attachment

To understand why scleroderma presents a specific risk, it helps to appreciate the biology of mucosal attachment around implants at a deeper level.

The peri-implant mucosal seal forms through two primary structures:

1. The junctional epithelium — a thin band of epithelial cells that adheres to the implant surface via hemidesmosomes and a basal lamina. This is the innermost component of the seal.

2. The connective tissue zone — a fibre-rich band below the junctional epithelium, which provides physical reinforcement.

Unlike the natural periodontal ligament — which anchors teeth to bone via perpendicular collagen fibres — implants do not have this structure. The connective tissue fibres run parallel to the implant surface, which offers a structurally weaker attachment overall.

In a healthy patient, the junctional epithelial seal is maintained through:

• Constant cellular renewal and migration
• Local immune surveillance by neutrophils and macrophages
• Adequate vascular support

In a patient with scleroderma, the abnormal collagen environment disrupts this cellular renewal process. Fibrotic tissue does not regenerate or remodel as efficiently as healthy tissue. The junctional epithelium may therefore be thinner, less adherent, or more prone to breakdown under inflammatory challenge.

This biological vulnerability is the central reason why scleroderma and dental implant soft tissue integrity must be evaluated on an individual basis.

---

Microstomia and Its Practical Impact on Implant Access and Hygiene

One of the most practically limiting features of scleroderma for dental care is microstomia — the progressive tightening of the perioral tissues that reduces mouth opening. This creates specific challenges for both clinicians and patients:

For dental procedures:

• Implant placement and restoration may be technically more demanding
• Access to posterior regions may be limited
• Impressions and radiographic imaging may require modification

For daily oral hygiene:

• Standard toothbrushes may be difficult to manoeuvre effectively
• Interdental cleaning around implants may be uncomfortable or mechanically difficult
• Patients may struggle to achieve the level of plaque removal needed to maintain peri-implant health

Tailored oral hygiene instruction is therefore an essential component of implant maintenance for scleroderma patients, not merely routine advice. Specialist tools — such as smaller-headed brushes, single-tufted brushes, and oral irrigators — may be recommended depending on the degree of restriction.

---

When Dental Assessment May Be Appropriate

If you have scleroderma and have dental implants — or are considering them — there are specific circumstances in which seeking a professional dental evaluation would be appropriate:

• Swelling or redness around an implant that persists for more than a few days
• Bleeding around the implant when brushing or when touched, particularly if this is a new change
• Discomfort or tenderness in the implant area
• Changes in bite or implant position that you can feel or notice
• Increased sensitivity in the tissues surrounding the implant
• Visible recession of gum tissue around the implant collar
• Bad taste or odour localised to the implant site
• Changes in mouth opening or tissue pliability that affect your ability to clean effectively

None of these symptoms should cause undue alarm on their own, but each warrants professional assessment. Early identification of peri-implant mucositis, before it progresses to bone-affecting peri-implantitis, significantly improves outcomes.

It is also advisable for patients with scleroderma to inform their dental team about any changes in their systemic condition, medication regimen, or symptom profile, as these factors may influence implant health.

---

Can Dental Implants Still Be Suitable for People with Scleroderma?

This is one of the most common questions patients in this situation ask, and it deserves a measured, balanced response.

Scleroderma is not an absolute contraindication to dental implant placement. However, it is a condition that requires careful pre-treatment evaluation and honest discussion about realistic outcomes. The key factors a dental clinician would assess include:

• Disease severity and stability — How well-controlled is the scleroderma? Is the patient in a stable phase?
• Current medication — Immunosuppressive drugs, corticosteroids, and vasodilators may each have implications for healing and infection risk
• Bone density and volume — Adequate bone is needed to support osseointegration
• Oral hygiene capacity — Can the patient realistically maintain peri-implant hygiene given mouth-opening limitations?
• Salivary function — Significant xerostomia may affect both healing and long-term bacterial control
• Degree of microstomia — This affects both procedural feasibility and long-term maintenance

Shared decision-making between the patient and their dental and medical teams is central to determining the most appropriate approach. For adults considering tooth replacement in the context of complex medical histories, discussing suitability for dental implants with a clinician who understands medically complex presentations is recommended.

---

Maintaining Oral Health with Scleroderma: Practical Advice

Whilst the challenges associated with scleroderma and oral health are real, there are practical measures patients can take to maintain peri-implant health and overall oral wellbeing:

Adapt your oral hygiene tools:

• Use a small-headed, soft-bristled electric toothbrush
• Consider a single-tufted brush for cleaning around implant collars
• Oral irrigators (water flossers) can help flush the peri-implant sulcus where access is limited

Address dry mouth proactively:

• Sip water regularly throughout the day
• Use alcohol-free, fluoride-based dry mouth products
• Discuss prescription saliva substitutes with your dentist if appropriate
• Avoid alcohol-containing mouthwashes, which can worsen dryness

Attend regular professional maintenance:

• More frequent professional cleaning appointments (every three to four months rather than six) may be recommended for implant patients with scleroderma
• Peri-implant tissue should be assessed at every visit using gentle probing
• Radiographic monitoring of bone levels should be conducted at regular intervals

Communicate openly with your dental team:

• Notify your dentist of any changes in your systemic condition
• Provide an up-to-date medication list at every appointment
• Discuss any difficulties with home hygiene so adjustments can be made

Maintain general systemic health:

• Managing scleroderma with your rheumatologist and medical team supports overall tissue health, including oral tissues

---

Key Points to Remember

• Scleroderma is a systemic autoimmune condition causing fibrosis and vascular changes that can affect oral tissues, including those surrounding dental implants.
• The soft tissue seal (peri-implant mucosa) around an implant collar may be compromised in scleroderma patients due to altered collagen architecture, reduced vascularity, and xerostomia.
• These changes can increase susceptibility to peri-implant mucositis and peri-implantitis, though the degree of risk varies individually.
• Scleroderma is not necessarily a contraindication to dental implants, but thorough pre-treatment assessment and ongoing monitoring are essential.
• Microstomia may create practical challenges for implant placement and home oral hygiene that require tailored professional support.
• Early professional assessment of any new symptoms around an implant is advisable, as early intervention significantly improves outcomes.

---

Frequently Asked Questions

Does having scleroderma mean I cannot have dental implants?

Not necessarily. Scleroderma does not automatically preclude dental implant treatment, but it does mean your suitability must be assessed very carefully on an individual basis. Factors such as disease stability, degree of mouth-opening restriction, salivary function, medication, and bone health all influence whether implants are appropriate in your specific situation. Your dental and medical teams should work together to reach a shared, informed decision. Treatment suitability cannot be determined without a full clinical assessment.

How does dry mouth caused by scleroderma affect implant health?

Saliva plays a critical antimicrobial role in the mouth, and its reduction creates conditions in which bacteria accumulate more readily around implant collars. This elevates the risk of peri-implant inflammation. Patients with scleroderma-related xerostomia may benefit from more frequent professional maintenance appointments, specific dry mouth products, and tailored oral hygiene instruction to compensate for reduced salivary protection.

What are the signs that the soft tissue around my implant may be compromised?

Signs that warrant professional assessment include persistent redness or swelling around the implant, bleeding on gentle brushing or touch, localised discomfort or tenderness, visible gum recession around the collar, a bad taste localised to the implant site, or any changes in how the implant feels when biting. These symptoms do not necessarily indicate a serious problem, but they should be evaluated promptly by a dental professional.

Can medications for scleroderma affect implant healing or the surrounding tissues?

Yes, some medications used to manage scleroderma — including immunosuppressants and corticosteroids — may influence healing capacity, infection risk, and tissue response. It is important to provide your dental team with a full and current medication list before any implant procedure. Your dentist may liaise with your rheumatologist or other specialist to ensure treatment is planned with your complete health picture in mind.

How often should I attend dental appointments if I have scleroderma and dental implants?

Patients with scleroderma and dental implants generally benefit from more frequent professional monitoring than the standard six-monthly recall. Appointments every three to four months are often recommended, allowing the dental team to assess peri-implant tissue health, provide professional cleaning, and identify early changes before they progress. The appropriate frequency should be determined individually based on your clinical situation.

Is the jaw or bone around implants also affected by scleroderma?

Scleroderma can affect the periodontal ligament space around natural teeth, and some studies have noted changes in alveolar bone structure in scleroderma patients. Whilst the evidence regarding bone health specifically around implants in scleroderma patients is still evolving, any systemic condition affecting tissue vascularity and healing capacity warrants careful radiographic monitoring of peri-implant bone levels over time.

---

Conclusion

The relationship between chronic systemic scleroderma and the soft tissue seal around a dental implant collar is a clinically meaningful one that deserves careful attention. The fibrotic changes, vascular compromise, xerostomia, and reduced tissue resilience associated with scleroderma can collectively affect the integrity of the peri-implant mucosal seal — the biological barrier that protects both the implant and the surrounding bone from bacterial infiltration.

This does not mean that dental implants are out of reach for people living with scleroderma. It means that a thorough, honest, and individualised clinical assessment is essential before any decision is made. With appropriate planning, tailored maintenance, and open communication between dental and medical teams, implant therapy may still be a viable option for carefully selected patients.

If you have scleroderma and are concerned about your implant health or are exploring tooth replacement options, speaking with a dental professional who is experienced in managing medically complex presentations is a constructive first step. For adults in London seeking specialist guidance on implant health and complex dental needs, professional consultation provides the most reliable pathway to safe, appropriate care.

Dental symptoms and treatment options should always be assessed individually during a clinical examination.

---

Disclaimer

This article is intended for general educational purposes only and does not constitute personalised dental advice. Individual diagnosis and treatment recommendations require a clinical examination by a qualified dental professional.

---

Written Date: 4 November 2026

Next Review Date: 4 November 2027